|Bid||339.98 x 1300|
|Ask||350.59 x 800|
|Day's Range||343.40 - 350.99|
|52 Week Range||196.78 - 404.20|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||81.28|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
They didn't want to sell Tesla ever, but their profits were just to enormous.
Dr. Charles Kennedy, CEO of Blue Ox Healthcare Partners, answers Barron’s readers’ questions on health-care innovation, delivery, and investing.
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.